Jeil Pharmaceutical Co.,Ltd. develops and distributes pharmaceutical products. The Company produces solid pharmaceuticals, injections, finished drugs, and antibiotics for the treatment of oncology, urology, neuropsychiatry, and endocrinology. Jeil Pharmaceutical markets its products worldwide.

[Revised] Details of Corporate Governance Report (2024.12)

Details of Corporate Governance Report (2024.12)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Jeil Pharmaceutical (271980 KS)

[Revised] Details of Corporate Governance Report (2024.12)

Details of Corporate Governance Report (2024.12)

Notice on Change of CEO

Outcome of Annual Shareholders' Meeting

Submission of Audit Report

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)